This is a federal contract award to Exact Sciences Corporation, a for-profit medical technology company specializing in advanced cancer diagnostic testing services. The contract, valued at $701,268.00, is a Blanket Purchase Agreement (BPA) call order under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule. The contract is for Oncotype DX testing services, which are genomic and molecular cancer diagnostic tests, and was awarded by the Department of Veterans...
This is a federal contract award to Exact Sciences Corporation, a for-profit medical technology company, to provide specialized Oncotype genomic-based testing services. The contract, with a ceiling value of $243,771.45, is a delivery order under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule. The contracting agency is the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 8. The contract does not have a set-aside...
This is a federal contract award to Exact Sciences Corporation, a for-profit medical technology company, for the provision of the Oncotype DX Breast Assay testing services. The contract, valued at $24,177.72, is a delivery order issued under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16. The contract has an ultimate completion date of September 30, 2025. No set-aside...
This federal contract award to Exact Sciences Corporation, a for-profit medical technology company, is for the provision of ONCOTYPE DX TESTING services to the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA). The contract has a ceiling value of $23,163.84 and is a Delivery Order issued under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule. The contract is a Firm Fixed Price arrangement with an ultimate...
This federal contract award was issued by the Veterans Integrated Service Network 17 (VISN 17) of the U.S. Department of Veterans Affairs (VA) to Exact Sciences Corp for the provision of Oncotype DX breast cancer testing services. The contract has a ceiling value of $41,447.52 and a performance period through August 17, 2024. This award is a call against a Blanket Purchase Agreement (BPA) under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule contract. No...
This is a firm fixed price contract awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 to Exact Sciences Corp, Exact Sciences Laboratories, LLC Division, to provide Oncotype DX testing services. The contract has a ceiling value of $12,771.72 and a period of performance through September 30, 2021. Exact Sciences is an experienced federal contractor, having provided a variety of cancer testing and diagnostic services to agencies such as the VA, Defense...
This is a federal contract award to Exact Sciences Corporation, a for-profit organization, to provide Genomic Oncotype DX laboratory testing services to the U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21. The contract has a ceiling value of $625,351.42 and is a firm fixed price delivery order awarded under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule. The contract has an ultimate completion date of September 30, 2026. No set-aside...
This is a $31,085.64 firm fixed price Blanket Purchase Agreement (BPA) contract awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Veterans Health Administration (VHA) to Exact Sciences Corp for the provision of its Oncotype DX cancer diagnostic test services. The contract has an ultimate completion date of June 4, 2024 and utilizes Exact Sciences' Multiple Award Schedule contract for Medical Laboratory Testing and Analysis Services. No set-aside designation was used. Exact...
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Exact Sciences Corp for the provision of Oncotype DX genetic testing services for breast cancer patients. The contract was awarded under Exact Sciences' GSA Federal Supply Schedule (FSS-621-II) for Medical Laboratory Testing and Analysis Services. The contract has a potential value of $169,244.04 and runs through September 30, 2022. No set-aside designation was...
This is a federal contract award to Exact Sciences Corporation, a for-profit medical technology company, for the provision of Oncotype DX testing services for breast and colon cancer. The contract, valued at $514,714.40, was awarded by the Defense Health Agency (DHA) under the Medical Laboratory Testing and Analysis Services (FSS-621-II) Federal Supply Schedule. The contract does not have a set-aside designation, indicating Exact Sciences Corporation's competitive positioning in the provision of...